Skip to content

Implementation research for improving the rate of intravenous thrombolysis in acute ischemic stroke patients - feasibility study

Implementation research for improving the rate of intravenous thrombolysis in acute ischemic stroke patients - feasibility study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0012063
Enrollment
107
Registered
2026-05-29
Start date
2025-02-18
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : : Monthly audit-and-feedback intervention delivered to stroke teams at participating hospitals. Components: (1) kick-off online monitoring meeting at intervention onset, reviewing the pre
(2) monthly feedback emails containing hospital-specific IVT rate, list of non-treated eligible patients, and benchmarking against top-quintile hospitals
(3) individualized prompts requiring physicians to respond to a structured questionnaire when an IVT-eligible patient is not treated.

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Doctors who treat acute ischemic stroke

Exclusion criteria

Exclusion criteria: Doctors who do not consent to participation in the study

Design outcomes

Primary

MeasureTime frame
Monthly hospital-level rate of intravenous thrombolysis (IVT) among all acute ischemic stroke patients who present during the study period

Secondary

MeasureTime frame
Monthly hospital-level IVT rate among IVT-eligible patients defined as: ? age =18 years with cerebral infarction; ? arrival within 4.5 hours of last known normal time; ? NIHSS score =1.

Countries

Korea, Republic of

Contacts

Public ContactHEE JOON BAE

Seoul National University Bundang Hospital

braindocbae@gmail.com+82-31-787-7467

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jun 11, 2026